Fluvastatin Effectively Reduces Cardiac Risk
This study found that renal transplant recipients had a 35% risk reduction for cardiac death or non-fatal myocardial infarction by taking fluvastatin, a cholesterol lowering medication. [ The Lancet Volume 361, Number 9373, 07 June 2003 ]
|
All times are GMT -8. The time now is 14:29. |
Powered by: vBulletin Version 3.0.3
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.